Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel
| Autor: | Ahmed, Nausheen, Wesson, William, Lutfi, Forat, Porter, David L., Bachanova, Veronika, Nastoupil, Loretta J., Perales, Miguel-Angel, Maziarz, Richard T., Brower, Jamie, Shah, Gunjan L., Chen, Andy I., Oluwole, Olalekan O., Schuster, Stephen J., Bishop, Michael R., McGuirk, Joseph P., Riedell, Peter A. |
|---|---|
| Zdroj: | In Blood Advances 22 October 2024 8(20):5346-5354 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|